Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Milan
Clinical trial register · Italy

Clinical Trials in Milan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
IRCCS San Raffaele160 AstraZeneca137 Merck Sharp & Dohme LLC98 Hoffmann-La Roche80 Novartis Pharmaceuticals73
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Milan

2846 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Novartis Pharmaceuticals
Phase 2/3
232
Bologna, Milan, Roma, Torino, Naples
2023-11-24
Recruiting
Azienda USL Reggio Emilia - IRCCS
Observational
3,000
Brindisi, Milan, Reggio Emilia, Trento
2023-11-23
Recruiting
AstraZeneca
Phase 3
625
Bergamo, Empoli, Milan, Modena, Naples, Padova, Reggio Emilia, Roma
2023-11-23
Recruiting
IRCCS San Raffaele
Observational
450
Milan
2023-11-21
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
100
Milan
2023-11-21
Active, closed
AstraZeneca
Phase 3
1,898
Bari, Genoa, Meldola, Milan, Naples, Padova, Rome, Rozzano
2023-11-21
Active, closed
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT06016738Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Exemestane·Anastrozole·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
510
Avellino, Bologna, Meldola, Modena, Reggio Emilia, Udine, Rome, Milan
2023-11-16
Recruiting
Amgen
Phase 3
750
Bari, Brescia, Candiolo, Catania, Florence, Meldola (FC), Milan, Monza (MB)
2023-11-16
Active, closed
Novartis Pharmaceuticals
Phase 3
470
Milan, Rozzano, Modena, Roma, Siena
2023-11-15
Recruiting
CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
NCT06158698Cardiomyopathies, Myocarditis, Inflammatory Cardiomyopathy, Heart Failure
DrugColchicine
Niguarda Hospital
Phase 3
80
Naples, Bologna, Trieste, Udine, Rome, Milan, Turin, Ancona
2023-11-14
Active, closed
AstraZeneca
Phase 3
1,902
Empoli, Lucca, Milan, Modena, Naples, Padova, Province of Macerata, Roma
2023-11-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Meldola, Turin, Palermo, Milan, Modena, Naples, Perugia, Pisa
2023-11-14
Active, closed
GlaxoSmithKline
Phase 2
316
Rozzano, Bari, Bologna, Florence, Genova, Milan, Naples, Novara
2023-11-14
Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
NCT06128551Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
DrugsElironrasib·Cetuximab
Revolution Medicines, Inc.
Phase 1/2
534
Verona, Ancona, Aviano, Meldola, Milan, Naples, Orbassano, Ravenna
2023-11-14
Recruiting
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673Alzheimer's Disease Psychosis
DrugACP-204
ACADIA Pharmaceuticals Inc.
Phase 2/3
1,074
Brescia, Cefalù, Isernia, Milan, Roma, Salerno, Torino, Tricase
2023-11-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
556
Meldola, Rome, Milan, Rozzano
2023-11-12
Active, closed
BeOne Medicines
Phase 3
652
Bologna, Ferrara, Milan, Novara, Padova, Perugia
2023-11-11
Recruiting
Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy Subjects
NCT07358013Von Willebrand Disease (VWD), Acquired Von Willebrand Disease
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
48
Milan
2023-11-11
Active, closed
AstraZeneca
Phase 3
863
Alessandria, Bari, Bergamo, Milan, Monza, Orbassano, Padova, Parma
2023-11-09
Active, closed
ASST Fatebenefratelli Sacco
Observational
126
Milan
2023-11-08
Active, closed
Pfizer
Phase 3
1,571
L’Aquila, Florence, Milan, Roma, Rome, Cagliari
2023-11-08
Recruiting
IRCCS San Raffaele
Not applicable
70
Milan
2023-11-08
Active, closed
AstraZeneca
Phase 3
314
Ancona, Brescia, Cona, Milan, Padova, Roma
2023-11-08
Active, closed
IRCCS San Raffaele
Observational
3
Milan
2023-11-08
Recruiting
Gruppo Oncologico del Nord-Ovest
Phase 2/3
300
Ancona, Bergamo, Bologna, Brescia, Cuneo, Meldola, Milan, Modena
2023-11-07
Active, closed
Bristol-Myers Squibb
Phase 2
100
Bergamo, Meldola, Milan, Padova, Roma, Torino, Naples
2023-11-06
Recruiting
Tethis S.p.A.
Observational
45
Milan
2023-11-06
Active, closed
TheraSphere With Durvalumab and Tremelimumab for HCC
NCT05063565Hepatocellular Carcinoma
Boston Scientific Corporation
Phase 2
100
Milan, Roma, Udine
2023-11-03
By invitation
Edgewise Therapeutics, Inc.
Phase 2
260
Milan, Padova, Rome
2023-11-02
Recruiting
IRCCS San Raffaele
Not applicable
60
Milan
2023-11-02
Recruiting
Follow up of High Myopic Eyes
NCT06322433Pathologic Myopia
Istituto Auxologico Italiano
Observational
138
Milan
2023-11-01
Not yet open
IRCCS San Raffaele
Observational
20
Milan
2023-11-01
Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
NCT05862012Relapsed/Refractory Multiple Myeloma
Ichnos Sciences SA
Phase 1
200
Brescia, Milan
2023-11-01
Active, closed
Ipsen
Observational
1,057
Foggia, Lecco, Milan, Novara, Salerno, Verona
2023-11-01
Recruiting
Fondazione Don Carlo Gnocchi ETS
Not applicable
60
Milan
2023-11-01
Not yet open
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2
35
Milan, Siena, Verona
2023-11
Recruiting
LeonaBio
Phase 3
600
Ancona, Aviano, Candiolo, Meldola, Milan, Misterbianco, Modena, Naples
2023-10-31
Active, closed
IDEAYA Biosciences
Phase 2/3
420
Milan, Naples, Roma, Siena
2023-10-31
Recruiting
MicroPort Orthopedics Inc.
Observational
45
Milan
2023-10-31
Recruiting
IRCCS San Raffaele
Observational
230
Milan
2023-10-30
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Ancona, Milan, Salerno, Naples
2023-10-27
Recruiting
Grupo Espanol de Tumores Neuroendocrinos
Phase 3
170
Reggio Emilia, Bari, Meldola, Milan, Roma, Verona
2023-10-27
Recruiting
Whole Body MRI in Oncology
NCT06895291Lymphoma, Advanced Prostate Cancer, Advanced Breast Cancer, Monoclonal Gammopathy of Undetermined Significance
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Observational
1,000
Bologna, Meldola, Milan
2023-10-26
Active, closed
Summit Therapeutics
Phase 3
1,600
Ancona, Aviano, Cremona, Genova, Lucca, Mantua, Milan, Monza
2023-10-26
Recruiting
Durvalumab and Tremelimumab in Resectable HCC
NCT05440864Hepatocellular Carcinoma
DrugsTremelimumab·Durvalumab
University Health Network, Toronto
Phase 2
28
Milan
2023-10-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Monserrato, San Giovanni Rotondo, Rome, Milan, Rozzano, Rho, Naples, Palermo
2023-10-25
Recruiting
Advances in Telephone-based Cognitive Screening Procedures
NCT06337578Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Lewy Body Dementia, Frontotemporal Degeneration
Istituto Auxologico Italiano
Observational
280
Milan
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Ancona, Modena, Florence, Milan, Pisa, Roma, Trieste, Bergamo
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
402
Rome, Milan, Rozzano, Turin, Florence, Bologna, Reggio Calabria, Roma
2023-10-24
Active, closed
AstraZeneca
Phase 3
895
Bari, Bergamo, Milan, Padova, Parma, Pavia, Ravenna, Roma
2023-10-24
Active, closed
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
NCT05952037Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory
DrugsSonrotoclax·Zanubrutinib
BeOne Medicines
Phase 2
114
Bologna, Brescia, Milan, Pavia, Roma, Udine
2023-10-23
Recruiting
Hoffmann-La Roche
Phase 3
182
Bologna, Bergamo, Milan, Alessandria, Turin
2023-10-22
Recruiting
Rescue Stenting and Intravenous Thrombolysis In Patients With Large Vessel Ischemic Stroke
NCT06727006Large Vessel Occlusion, Stroke Acute, Thrombolysis, Rescue Stenting
ASST Santi Paolo e Carlo
Observational
400
Bergamo, Cesena, Lecce, Milan, Monza, Pietra Ligure
2023-10-21
Recruiting
W.L.Gore & Associates
Not applicable
244
Milan, Perugia, Roma, Turin
2023-10-17
Recruiting
Istituto Auxologico Italiano
Observational
186
Milan
2023-10-17
Recruiting
Università Vita-Salute San Raffaele
Observational
1,456
Milan
2023-10-16
Recruiting
Automatic Voice Analysis for Dysphagia Screening in Neurological Patients
NCT06219200Deglutition Disorders, Neurological Disorder
Istituti Clinici Scientifici Maugeri SpA
Observational
400
Lissone, Milan
2023-10-11
Recruiting
Sanofi
Phase 3
180
Milan, Padua, Palermo, Pavia, Siena
2023-10-10
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Cona, Rome, Bergamo, Brescia, Milan, Monza, Turin, Palermo
2023-10-09
Recruiting
Tethis S.p.A.
Observational
200
Milan
2023-10-09
Recruiting
Optical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)
NCT07720765Multiple Sclerosis, Alzheimer Disease, Parkinson Disease, Migraine
IRCCS San Raffaele
Observational
1,050
Milan
2023-10-09
Recruiting
dr. M.J.N.L. Benders
Observational
1,000
Florence, Genova, Milan, Pisa
2023-10-06
Active, closed
AstraZeneca
Phase 3
5,511
Bergamo, Bologna, Florence, Genoa, Meldola, Milan, Misterbianco, Monza
2023-10-05
Recruiting
Montefiore Medical Center
Observational
800
Milan
2023-10-05
Recruiting
Acrotech Biopharma Inc.
Phase 3
504
Tricase, Milan, Meldola, Borgo Roma, Alessandria, Genova, Parma, Pavia
2023-10-04
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
50
Rome, Milan, Pisa
2023-10-03
By invitation
Biogen
Phase 3
306
Florence, Milan
2023-10-03
Active, closed
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
180
Sesto Fiorentino, Brescia, Milan
2023-10-03
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Bari, Ranica, Brescia, Milan, Roma, Torino, Naples
2023-10-02
Recruiting
Abbott Medical Devices
Observational
1,000
Brescia, Castel Volturno, Milan, Palermo, Roma, San Donato Milanese, Torino
2023-09-29
Active, closed
Tensive SRL
Not applicable
92
Rozzano, Catania, Milan, Pavia, Pisa, Roma, Torino
2023-09-29
Recruiting
University of Manchester
Observational
40
Milan
2023-09-28
Recruiting
Deciphera Pharmaceuticals, LLC
Phase 1/2
94
Florence, Genova, Milan
2023-09-28
By invitation
Sarepta Therapeutics, Inc.
Phase 3
400
Genova, Milan, Roma
2023-09-27
Active, closed
Zenas BioPharma (USA), LLC
Phase 3
134
Milan
2023-09-25
Active, closed
Incyte Corporation
Phase 1
160
Bologna, Florence, Milan
2023-09-25
Recruiting
AstraZeneca
Phase 3
800
Bari, Bologna, Catania, Florence, Lecco, Milan, Monza, Naples
2023-09-22
Active, closed
Ad scientiam
Not applicable
336
Florence, Foggia, Milan
2023-09-22
Active, closed
AbbVie
Phase 2
130
Florence, Milan, Naples, Bologna, Palermo, Roma
2023-09-21
Recruiting
Hoffmann-La Roche
Phase 1/2
60
Milan, Rozzano (MI)
2023-09-21
Active, closed
Pembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder Cancer
NCT05535218Muscle-invasive Urothelial Carcinoma of the Bladder
Claudia Guerrieri
Phase 2
48
Milan
2023-09-20
Active, closed
Bayer
Phase 1
232
Milan, Naples
2023-09-20
Recruiting
Mesenchymal Stromal Cells for Traumatic Brain Injury
NCT06163833Traumatic Brain Injury With Loss of Consciousness
Fondazione IRCCS San Gerardo dei Tintori
Phase 2
78
Monza, Bergamo, Milan
2023-09-19
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Naples, Bologna, Modena, Genoa, Bergamo, Milan, Rozzano, Catania
2023-09-18
Active, closed
Mario Negri Institute for Pharmacological Research
Phase 4
190
San Fermo della Battaglia, Brescia, Florence, Lecco, Lucca, Milan, Padova, Parma
2023-09-15
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Bologna, Modena, Florence, Milan, Pisa, Roma, Ancona, Bergamo
2023-09-14
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
DrugBelimumab
GlaxoSmithKline
Phase 2/3
300
Roma, Ancona, Bari, Cagliari, Catania, Ferrara, Florence, Milan
2023-09-13
By invitation
argenx
Phase 3
240
Bari, Milan, Pisa, Roma, Rozzano, Udine
2023-09-12
Recruiting
European Breast Cancer Research Association of Surgical Trialists
Observational
1,236
Milan, Roma
2023-09-12
Recruiting
Blood Tests for Alzheimer's Disease: Can Plasma Biomarkers Diagnose and Predict Disease Progression
NCT07717567Alzheimer Disease, Mild Cognitive Impairment, Subjective Cognitive Decline, Dementia
IRCCS San Raffaele
Observational
2,000
Milan
2023-09-12
Active, closed
Bristol-Myers Squibb
Phase 3
774
Brescia, Milan, Naples, Pisa, Rome, Udine
2023-09-11
Recruiting
European Institute of Oncology
Observational
270
Milan
2023-09-11
Recruiting
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
NCT06035250Gastric Cancer, Image, Pathology
Chinese Academy of Sciences
Observational
200
Milan
2023-09-10
Recruiting
Hoffmann-La Roche
Phase 3
230
Meldola, Rome, Milan, Monza, Novara, Palermo, Bagno a Ripoli, Verona
2023-09-08
Recruiting
Rescue of Nephrons With ALE.F02 (RENAL-F02)
NCT06047171Glomerulonephritis Rapidly Progressive
DrugsCyclophosphamid·Rituximab
Alentis Therapeutics AG
Phase 2
80
Bergamo, Florence, Milan, Rome, Trento
2023-09-07
Recruiting
Gilead Sciences
Phase 3
402
Ancona, Castellana Grotte, Milan, Modena, Monza, Padova, Palermo, Pisa
2023-09-07
Recruiting
Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome
NCT05926505Post-Acute COVID-19 Syndrome, Post-Acute COVID-19, Long COVID
DrugAnakinra
Hellenic Institute for the Study of Sepsis
Phase 2/3
182
Genova, Jesolo, Milan, Modena, Rome
2023-09-06
Recruiting
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
NCT05365659B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma
Iksuda Therapeutics Ltd.
Phase 1
140
Candiolo, Milan
2023-09-05
Recruiting
The Lymphoma Academic Research Organisation
Phase 3
260
Bologna, Castelfranco Veneto, Cuneo, Latina, Lecce, Milan, Modena, Pavia
2023-09-05
Recruiting
The ReTAVI Prospective Observational Registry
NCT05601453Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction
Institut für Pharmakologie und Präventive Medizin
Observational
250
Ancona, Bologna, Brescia, Florence, Milan, Padua, Pisa, Roma
2023-09-05
Recruiting
Fondazione Don Carlo Gnocchi ETS
Observational
40
Genova, Milan
2023-09-01
Active, closed
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731Ventricular Arrhythmia, Tachycardia
Medtronic
Observational
1,000
Bari, Bologna, Milan, Monza
2023-09-01
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
NCT06051409Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
DrugOlverembatinib
Ascentage Pharma Group Inc.
Phase 3
350
Bologna, Meldola, Milan, Monza, Ravenna, Roma, Torino, Varese
2023-08-31
Active, closed
AnaptysBio, Inc.
Phase 2
420
Milan, Pavia, Bari, Novara, Roma
2023-08-31
Recruiting
IGLESIAS Juan Fernando
Not applicable
708
Milan
2023-08-31
Active, closed
Cytokinetics
Phase 3
500
San Donato Milanese, Brescia, Florence, Foggia, Milan, Naples, Pisa, Roma
2023-08-31
Recruiting
Imaging Biomarkers to Stratify the Risk of Barotrauma in ARDS
NCT05816954Acute Respiratory Distress Syndrome, Barotrauma
Università Vita-Salute San Raffaele
Observational
100
Catanzaro, Milan
2023-08-30
Recruiting
AviadoBio Ltd
Phase 1/2
18
Milan
2023-08-30
Recruiting
Chinese Academy of Sciences
Not applicable
400
Milan
2023-08-29
Active, closed
Novartis Pharmaceuticals
Phase 2
144
Bologna, Milan, San Giovanni Rotondo
2023-08-25
Recruiting
AstraZeneca
Observational
52,121
Lecce, Messina, Milan
2023-08-21
Active, closed
Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)
NCT05792332Atypical Parkinsonism, MSA - Multiple System Atrophy, PSP, Nurse-Patient Relations
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Not applicable
164
Messina, Milan, Pavia, Pozzilli
2023-08-17
Active, closed
Emalex Biosciences Inc.
Phase 3
150
Genova, Naples, Roma, Catania, Milan
2023-08-16
Active, closed
Fundacao Champalimaud
Not applicable
1,030
Milan
2023-08-08
Recruiting
Merck Sharp & Dohme LLC
Phase 3
735
Alessandria, Milan, Reggio Emilia
2023-08-08
Recruiting
Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase
NCT06119269Chronic Myeloid Leukemia, Chronic Phase
University of Pisa
Observational
100
Cagliari, Milan, Naples, Pisa, Roma
2023-08-02
Recruiting
Ischemic And Bleeding Risk Assessment After TAVR
NCT06000943Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement
Niguarda Hospital
Observational
2,500
Milan, Rozzano, San Donato Milanese, Genova, Potenza, Roma, Torino
2023-08-01
Recruiting
GlaxoSmithKline
Phase 3
892
Cagliari, Genova, Milan, Naples, Padova, Pisa, Reggio Emilia, Roma
2023-08-01
Recruiting
Istituto Auxologico Italiano
Observational
1,000
Milan, Naples
2023-08-01
Recruiting
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
NCT05967689Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
DrugZipalertinib
Taiho Oncology, Inc.
Phase 2
220
Florence, Meldola, Cremona, Milan, Parma, Ravenna
2023-07-31
Recruiting
Incyte Corporation
Phase 1
570
Milan, Rozzano, Verona
2023-07-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Milan, Siena, Perugia, Naples
2023-07-19
Active, closed
Hoffmann-La Roche
Phase 2
83
Ravenna, Milan
2023-07-18
Recruiting
Kartos Therapeutics, Inc.
Phase 2/3
268
Catania, Forlì, Genoa, Lecco, Lucca, Milan, Parma, Piacenza
2023-07-17
Recruiting
Prehabilitation in Pancreatic Surgery
NCT06069297Pancreatic Cancer, Periampullary Cancer, Frailty Syndrome, Malnutrition
IRCCS San Raffaele
Not applicable
238
Milan
2023-07-14
Recruiting
Fondazione Don Carlo Gnocchi ETS
Not applicable
40
Milan
2023-07-14
Recruiting
Anesthesia and Critical Care Registry
NCT06033404Anesthesia, Critical Care
Università Vita-Salute San Raffaele
Observational
30,000
Milan
2023-07-12
Recruiting
Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation
NCT05961865Atrial Fibrillation, Marker of Inflammation, Inflammation, Arrhythmia
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
180
Milan
2023-07-11
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Salerno, Rome, Brescia, Milan, Baggiovara, Ponderano (Biella), Florence, Monza
2023-07-11
By invitation
Robotic Surgery in Pulmonary Metastasectomy
NCT06466070Primary Solid Tumors
Scientific Institute San Raffaele
Observational
1,650
Rome, Milan, Rozzano
2023-07-11
Active, closed
Zenith Thoracic Alpha (ZTA) Post-Market Data Collection
NCT06094127Thoracic Aortic Aneurysm, Penetrating Aortic Ulcer
Cook Research Incorporated
Observational
300
Bologna, Milan
2023-07-06
Recruiting
Istituto Auxologico Italiano
Not applicable
90
Milan
2023-07-03
Active, closed
IDEAYA Biosciences
Phase 2
160
Milan, Rome
2023-07-03
Recruiting
Niguarda Hospital
Observational
300
Milan
2023-07-01
Not yet open
University of Milan
Phase 2/3
70
Milan
2023-07
Recruiting
Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells
NCT06194669Carcinoma, Renal Cell, Von Hippel-Lindau Disease
IRCCS San Raffaele
Observational
50
Milan
2023-06-30
Recruiting
Friedreich's Ataxia Research Alliance
Observational
3,000
Conegliano, Milan, Roma
2023-06-28
Active, closed
OncoC4, Inc.
Phase 3
630
Ancona, Bari, Bergamo, Catania, Milan, Monza, Naples, Palermo
2023-06-28
Active, closed
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT05696717Symptomatic Neurogenic Orthostatic Hypotension, MSA - Multiple System Atrophy
Theravance Biopharma
Phase 3
102
Bologna, Milan, Rome, Salerno, Terni, Trento, Tricase
2023-06-27
Active, closed
AstraZeneca
Phase 3
111
Milan, Naples, Padova, Pisa, Rozzano, Turin
2023-06-27
Active, closed
Novartis Pharmaceuticals
Phase 1
123
Milan, Rozzano
2023-06-27
Active, closed
Swedish Orphan Biovitrum
Observational
165
Bari, Bassano del Grappa, Bologna, Cagliari, Florence, Milan, Novara, Reggio Calabria
2023-06-26
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
12
Milan, Roma, Torino
2023-06-24
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
390
Naples, Milan
2023-06-23
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Catania, Florence, Genova, Milan, Pisa, Roma, Torino, Naples
2023-06-22
Active, closed
AbbVie
Phase 3
1,328
Cona, Florence, L’Aquila, Rome, Brescia, Milan, Modena, Pisa
2023-06-21
Active, closed
Exact Sciences Corporation
Observational
416
Rozzano, Milan, Naples
2023-06-20
Recruiting
Hoffmann-La Roche
Phase 1/2
320
Naples, Rome, Milan, Orbassano
2023-06-20
Recruiting
Centro Cardiologico Monzino
Observational
300
Milan
2023-06-19
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna, Rozzano, Palermo, Genova, Milan, Modena, Naples, Padova
2023-06-19
Recruiting
Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure
NCT06918912Diffuse Large B-Cell Lymphoma, High-grade B-cell Lymphoma (HGBCL), B-Cell Lymphoma Treatment, Relapsed or Refractory Lymphoma
DrugLoncastuximab Tesirine
Istituto Clinico Humanitas
Phase 2
50
Alessandria, Bologna, Cuneo, Milan, Rozzano, Roma
2023-06-16
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
23
Milan
2023-06-16
Active, closed
RHEACELL GmbH & Co. KG
Phase 3
91
Milan, Roma
2023-06-13
Recruiting
National Cancer Institute, Naples
Phase 2
240
Naples, Milan, Roma, Verona
2023-06-12
Active, closed
Alfasigma S.p.A.
Observational
509
Bari, Milan, Pisa, Negrar, Palermo, Rozzano, Torino
2023-06-12
Active, closed
AbbVie
Phase 1
135
Milan, Turin, Bergamo, Bologna
2023-06-09
Active, closed
AbbVie
Observational
1,019
Florence, Rozzano, Milan, Rome, Bari, Bologna, Messina
2023-06-09
Recruiting
H. Lundbeck A/S
Phase 3
315
Cagliari, Genoa, Milan, Pavia, Pisa, Rome
2023-06-08
Active, closed
Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism
NCT05778071Chronic Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases
Alexion Pharmaceuticals, Inc.
Phase 3
165
Bologna, Florence, Milan, Pisa, Roma
2023-06-07
Recruiting
Hoffmann-La Roche
Phase 3
420
Caserta, Meldola, Ravenna, Aviano, Milan, Alessandria, Turin, Misterbianco (CT)
2023-06-07
Active, closed
Assessment of Trunk Aesthetics: Development of a New Tool
NCT05912140Adolescent Idiopathic Scoliosis
Istituto Scientifico Italiano Colonna Vertebrale
Observational
600
Milan
2023-06-06
By invitation
AbbVie
Phase 3
650
Milan, Palermo
2023-06-05
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
80
Torino, Milan
2023-06-05
Recruiting
Outcomes of ICT Assistive Technology in RehabiliTAtIoN Pathways
NCT06546813Communication Aids for Disabled, Communication Disorders, Motor Disorders, Cognitive Disorder
Fondazione Don Carlo Gnocchi ETS
Observational
50
Milan
2023-06-01
Recruiting
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
NCT06708429Lynch Syndrome, Lynch Syndrome I, Lynch Syndrome II, Lynch Syndrome I (Site-specific Colonic Cancer)
San Raffaele University
Observational
300
Milan, Palermo, Cagliari
2023-06-01
Active, closed
ArriVent BioPharma, Inc.
Phase 3
398
Rozzano, Aviano, Roma, Bari, Meldola, Milan
2023-06-01
Active, closed
University of Milan
Observational
200
Milan
2023-06-01
Recruiting
IRCCS Fondazione Stella Maris
Observational
300
Brindisi, Milan, Calambrone
2023-06-01
Active, closed
Sarepta Therapeutics, Inc.
Phase 3
148
Genova, Milan, Roma
2023-05-31
Recruiting
European Aortic Data Collection Project
NCT05896397Complex Abdominal Aortic Aneurysm, Thoracoabdominal Aortic Aneurysm, Aortic Arch Aneurysm, Chronic Aortic Dissection
Cook Research Incorporated
Observational
600
Bologna, Genova, Milan
2023-05-31
Active, closed
ML Bio Solutions, Inc.
Phase 3
112
Milan
2023-05-31
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
Genoa, Milan, Turin, Rome, Florence, Padova
2023-05-31
Recruiting
Gait and Balance Impairment in Rare and Very Rare Neurological Diseases
NCT06343558Multiple Sclerosis, Parkinson Disease, Peripheral Neuropathy, Rare Diseases
Istituto Auxologico Italiano
Observational
200
Milan
2023-05-30
Active, closed
Apellis Pharmaceuticals, Inc.
Phase 3
100
Milan, Ranica, Rome
2023-05-29
Recruiting
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Not applicable
105
Milan
2023-05-25
Recruiting
IRCCS San Raffaele
Observational
1,108
Milan
2023-05-22
Recruiting
Trustworthy, Integrated Artificial Intelligence Tools for Predicting High-risk CORonary PlaqueS
NCT06410690Coronary Artery Disease, Coronary Computed Tomography Angiography
Centro Cardiologico Monzino
Observational
4,000
Milan
2023-05-22
Active, closed
Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices
NCT07480187Parkinson Disease, Synucleinopathy, Alzheimer Disease
Azienda Ospedaliera di Perugia
Not applicable
340
Messina, Milan, Perugia
2023-05-20
Recruiting
A.O.U. Città della Salute e della Scienza
Observational
200
Milan, Naples, Torino
2023-05-20
Recruiting
Pfizer
Phase 3
318
Rozzano, Roma, Catania, Milan
2023-05-20
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Not applicable
208
Milan
2023-05-19
Active, closed
Janssen Research & Development, LLC
Phase 1/2
71
Milan, Orbassano, Verona
2023-05-18
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 1/2
7
Milan
2023-05-16
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
230
Meldola, Milan, Pisa, Padova
2023-05-16
Recruiting
Gruppo Oncologico del Nord-Ovest
Phase 2
197
Milan
2023-05-11
Recruiting
Azienda Usl di Bologna
Observational
300
Bologna, Milan
2023-05-10
Active, closed
Gilead Sciences
Phase 3
654
Ancona AN, Aviano, Bergamo, Bologna, Catania, Catanzaro, Genova GE, Milan
2023-05-08
Recruiting
OPErA Orchestral Posture Egonomic Assessment
NCT06758349Abnormal Posture
Fondazione Don Carlo Gnocchi ETS
Observational
250
Milan
2023-05-05
Active, closed
Phase III Study of AK112 for NSCLC Patients
NCT06396065Non-Squamous Non-small Cell Lung Cancer
DrugsIvonescimab·Pemetrexed·Carboplatin
Summit Therapeutics
Phase 3
420
Milan, Parma, Roma, Rome
2023-05-04
Active, closed
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
NCT05831176Eosinophilic Gastritis (EoG), Eosinophilic Duodenitis (EoD), Eosinophilic Gastrointestinal Disease (EGID), Eosinophilic Gastroenteritis
DrugDupilumab
Regeneron Pharmaceuticals
Phase 2
22
Rozzano, Palermo, Bari, Milan, Pisa, Roma, Rome
2023-05-03
Active, closed
Servier Affaires Médicales
Phase 3
299
Bologna, Florence, Milan, Naples, Reggio Emilia, Roma, Rozzano, San Giovanni Rotondo
2023-05-03
Active, closed
Aziende Chimiche Riunite Angelini Francesco S.p.A
Observational
300
Milan
2023-05-02
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
100
Milan
2023-05-01
Recruiting
AbbVie
Phase 3
450
Milan, Rome, Palermo
2023-05-01
Recruiting
Automated Fetal Cardiac Function in Babies Affected by Heart Diseases
NCT05698277Congenital Heart Defect, Cardiac Function
Anna Erenbourg
Observational
495
L’Aquila, Milan, Trieste
2023-05-01
Recruiting
Relationship Between Lifestyle Indicators and Cardiovascular Clinical Parameters
NCT06283069Cardiovascular Diseases, Lifestyle, Nutrition, Healthy, Physical Inactivity
Istituto Auxologico Italiano
Observational
100
Milan
2023-05-01
Active, closed
Prof. Massimo Filippi
Not applicable
80
Milan, Verona
2023-04-30
Active, closed
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
650
Milan
2023-04-30
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NCT05440851Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High
University Health Network, Toronto
Not applicable
6,250
Cona, Foggia, Milan, Legnano, Palermo, Roma, Sassari, Trento
2023-04-30
By invitation
ASST Fatebenefratelli Sacco
Not applicable
60
Milan
2023-04-30
Active, closed
Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)
NCT05804045Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath
DrugPimicotinib
Abbisko Therapeutics Co, Ltd
Phase 3
94
Bologna, Milan, Prato
2023-04-27
Active, closed
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
NCT05705973Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
Terumo Europe N.V.
Observational
3,000
Milan
2023-04-25
Active, closed
AstraZeneca
Phase 2
294
Florence, Milan, Naples, Rozzano
2023-04-24
Recruiting
Consorzio Oncotech
Phase 2
118
Brescia, Candiolo, Catania, Cremona, Florence, Genova, Milan, Modena
2023-04-18
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Bologna, Brescia, Meldola, Milan, Monza, Naples, Padova, Pisa
2023-04-18
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
NCT05786924Non-small Cell Lung Cancer, Histiocytic Neoplasm, Histiocytosis, BRAF Gene Mutation
DrugsPanitumumab·Folfox·Cetuximab·Nab-paclitaxel
Institut de Recherches Internationales Servier
Phase 1/2
554
Milan, Rome, Rozzano
2023-04-18
Active, closed
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
NCT05626855Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2, SMA
DrugApitegromab
Scholar Rock, Inc.
Phase 3
238
Genova, Messina, Milan, Roma
2023-04-17
Recruiting
Eli Lilly and Company
Phase 1/2
880
Alessandria, Brescia, Milan, Monza, Pisa, Ravenna, Roma, Verona
2023-04-17
Recruiting
Early Onset Colorectal Cancer Detection
NCT06342401Colorectal Cancer, Colorectal Neoplasms, Colorectal Adenocarcinoma, Colorectal Cancer Stage I
City of Hope Medical Center
Observational
400
Milan
2023-04-15
Recruiting
European Institute of Oncology
Observational
2,000
Milan
2023-04-14
Active, closed
Umecrine Cognition AB
Phase 1/2
202
Milan, Padova, Palermo, Roma, Rozzano, Udine
2023-04-14
Active, closed
Hoffmann-La Roche
Phase 2
204
Bari, Naples, Bologna, Meldola, Rome, Milan, Terni, Padova
2023-04-13
Recruiting
Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer
NCT06627998Cancer of Thyroid, Vertebral Fracture, Osteoporosis
IRCCS San Raffaele
Observational
82
Milan
2023-04-12
Recruiting
Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis
NCT06318598Amyotrophic Lateral Sclerosis, Motor Neuron Disease
Istituto Auxologico Italiano
Observational
200
Milan, Torino
2023-04-11
Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
NCT05544019Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL, Waldenstrom Macroglobulinemia
Schrödinger, Inc.
Phase 1
98
Alessandria, Milan, Torino, Verona
2023-04-10
By invitation
Artificial Intelligence to Predict Surgical Outcomes and Assess Pain Neuromodulation in Trigeminal Neuralgia Subjects
NCT05810428Trigeminal Neuralgia, Trigeminal Nerve Diseases, Virtual Reality, Artificial Intelligence
IRCCS San Raffaele
Not applicable
50
Milan
2023-04-06
Active, closed
AstraZeneca
Phase 3
94
Milan, Roma
2023-04-05
Active, closed
Metformin and Nightly Fasting in Women With Early Breast Cancer
NCT05023967Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma
DrugsGlucophage·Metformin Hydrochloride
M.D. Anderson Cancer Center
Phase 2
120
Genoa, Milan
2023-04-04
Active, closed
GlaxoSmithKline
Phase 2
154
Milan, Padova, Roma
2023-04-03
Active, closed
Sanofi
Phase 2
999
Milan, Naples, Rome, Brescia, Vicenza
2023-04-03
Recruiting
Creation of a Clinical Database for the Study of Phenotypic Variability in Motor Neuron Diseases
NCT06318585Amyotrophic Lateral Sclerosis, Motor Neuron Disease
Istituto Auxologico Italiano
Observational
200
Milan
2023-04-03
Recruiting
Istituto Superiore di Sanità
Observational
296
Como, Milan, Naples, Rome
2023-04-01
Recruiting
Checkmab S.r.l.
Observational
600
Milan
2023-04-01
Recruiting
AstraZeneca
Phase 3
4,300
Bari, Catania, Catanzaro, Florence, Genova, Grosseto, Milan, Modena
2023-03-31
Active, closed
Bial R&D Investments, S.A.
Phase 2
237
Bologna, Brescia, Brindisi, Milan, Naples, Padova, Roma, Rozzano
2023-03-31
Recruiting
Iovance Biotherapeutics, Inc.
Phase 3
670
Meldola, Aviano, Naples, Pisa, Milan, Siena
2023-03-30
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Bologna, Milan, Palermo, Pisa, Reggio Emilia, Roma, Siena, Turin
2023-03-29
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Acquaviva delle Fonti, Asti, Avellino, Castelfranco Veneto, Milan, Naples, Ravenna, Rome
2023-03-23
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
1,650
Bologna, Florence, Milan, Padova, Roma, Torino
2023-03-21
Recruiting
Role of the Gut Vascular Barrier and Microbiota in Autism Spectrum Disorders
NCT07450443Autism, Autism Disorder, Autism Spectrum Disorder (ASD)
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Phase 2/3
90
Milan
2023-03-21
Recruiting
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression
NCT06292897Prostate Cancer, Prostate Adenocarcinoma, Prostate Neoplasm, Prostatic Neoplasm
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
25
Milan
2023-03-20
By invitation
G7 Dual Mobility With Vivacit-E or Longevity PMCF
NCT05548972Hip Osteoarthritis, Rheumatoid Arthritis, Joint Diseases, Avascular Necrosis
Zimmer Biomet
Not applicable
358
Milan
2023-03-20
Active, closed
AbbVie
Phase 3
520
Florence, Meldola, Genoa, Rozzano, Milan, Naples, Rome, Mirano
2023-03-15
Recruiting
YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.
NCT06337760Neuroendocrine Neoplasm, Adenocarcinoma
European Institute of Oncology
Observational
90
Milan
2023-03-10
Recruiting
Provocative Tests for HFpEF
NCT06309550Heart Failure With Preserved Ejection Fraction
Istituto Auxologico Italiano
Observational
500
Milan
2023-03-10
Recruiting
Spanish Oncology Genito-Urinary Group
Phase 2
90
Milan, Turi, Turin
2023-03-07
Active, closed
AstraZeneca
Phase 2
188
Avellino, Brescia, Lecce, Milan, Naples, Palermo, Peschiera del Garda, Reggio Emilia
2023-03-06
Recruiting
Takeda
Phase 3
160
Milan, Palermo, Pavia, Rozzano
2023-03-06
Active, closed
Bristol-Myers Squibb
Phase 3
579
Genova, Siena, Bari, Milan, Naples, Perugia, Roma
2023-03-06
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Not applicable
566
Milan
2023-03-01
Recruiting
FDG-PET in the Diagnosis of Autoimmune Encephalitis
NCT06019975Autoimmune Encephalitis
University of Milano Bicocca
Observational
90
Udine, Genoa, Pavia, Milan, Monza
2023-03-01
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Not applicable
260
Milan
2023-03-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
65
Bologna, Caserta, Bari, Ferrara, Florence, Milan, Novara, Padova
2023-03-01
Active, closed
Novartis Pharmaceuticals
Phase 2
33
Brescia, Florence, Genova, Milan, Roma
2023-02-28
Active, closed
AlgoTherapeutix
Phase 2
276
Campobasso, Meldola, Milan, Monza, Pavia, Roma
2023-02-28
Active, closed
Multiomics Approach in Metastatic Clear Renal Cell Carcnoma
NCT05782400Metastatic Clear Cell Renal Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
100
Milan
2023-02-28
Active, closed
AstraZeneca
Observational
551
Naples, Cona, Udine, Rome, Brescia, Milan, Turin, Cagliari
2023-02-27
Active, closed
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
DrugsTovorafenib·Carboplatin
Day One Biopharmaceuticals, Inc.
Phase 3
418
Milan, Roma, Torino, Bari, Florence, Genova, Naples, Padova
2023-02-27
Recruiting
D-SOLVE Cohorts (Cohort A and B)
NCT06160635HDV, HDV Infection, Chronic Liver Disease
Hannover Medical School
Observational
750
Milan
2023-02-22
Recruiting
Fore Biotherapeutics
Phase 2
254
Meldola, Naples, Milan
2023-02-21
Active, closed
Gilead Sciences
Phase 2
400
Meldola, Milan, Padova, Pesaro, Rome
2023-02-21
Recruiting
European Institute of Oncology
Not applicable
60
Milan
2023-02-20
Recruiting
COronary Re-engageMent aFter randOm NavitoR alignmenT (COMFORT STUDY)
NCT05779787Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement
Niguarda Hospital
Observational
100
Milan
2023-02-15
Recruiting
IRCCS San Raffaele
Observational
100
Milan
2023-02-15
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Rome, Florence, Milan, Naples, Roma, Torino
2023-02-13
Active, closed
Primary Care-Hospital Embedding: a Prospective, Multicentric, Observational Study
NCT05723185Heart Failure, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, Pneumonia
Rovere Querini Patrizia
Observational
246
Milan
2023-02-13
Recruiting
Novartis Pharmaceuticals
Phase 3
195
Milan, Modena, Roma
2023-02-10
Active, closed
Kite, A Gilead Company
Phase 3
300
Bologna, Brescia, Milan, Perugia, Reggio Calabria, Rome, Rozzano
2023-02-10
Active, closed
Genmab
Phase 3
900
Alessandria, Bari, Brescia, Bologna, San Giovanni Rotondo, Milan, Naples, Palermo
2023-02-08
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
160
Milan, Siena, Aviano, Brescia, Cuneo, Florence, Novara, Padova
2023-02-08
Recruiting
Novel Non-invasive Brain Stimulation Techniques in Neurological Rehabilitation
NCT05766059Stroke, Hemiparesis, Phantom Limb Pain
Istituto Auxologico Italiano
Not applicable
36
Milan
2023-02-08
Recruiting
Medtronic Cardiovascular
Not applicable
400
Bologna, Brescia, Milan, Pisa, San Donato Milanese
2023-02-07
Active, closed
Hoffmann-La Roche
Phase 2
51
Rome, Milan
2023-02-07
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
1,000
Milan
2023-02-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
614
Rome, Bergamo, Milan, Naples, Florence, Peschiera del Garda, Parma
2023-02-06
Active, closed
Hoffmann-La Roche
Phase 2
301
Bologna, Rome, Milan
2023-02-03
Recruiting
START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
NCT05492682Melanoma (Skin), Triple-Negative Breast Cancer, Non-Small Cell Lung Cancer, Synovial Sarcoma
DrugsCyclophosphamide·Pembrolizumab
Valo Therapeutics Oy
Phase 1
15
Candiolo, Milan, Naples
2023-02-02
Recruiting
Tampere University
Not applicable
12,000
Genova, Milan, Rome, Turin
2023-02-01
Active, closed
Sanofi
Phase 3
91
Rozzano, Milan
2023-02-01
Recruiting
Inotrem
Observational
40
Milan
2023-01-31
Recruiting
Tenaya Therapeutics
Observational
200
Milan, Pavia
2023-01-31
Recruiting
Istituto Clinico Humanitas
Not applicable
146
Brescia, Florence, Rozzano, Milan, Naples, Rome, Terni
2023-01-31
Active, closed
Registry on Percutaneous Electrochemotherapy
NCT05267080Primary Liver Cancer, Secondary Liver Cancer
Cardiovascular and Interventional Radiological Society of Europe
Observational
250
Milan, Rome
2023-01-25
Active, closed
Stemline Therapeutics, Inc.
Phase 1/2
435
Brescia, Milan, Naples, Rimini
2023-01-24
Active, closed
TVMR With the Innovalve System Trial - Pilot Study in Italy
NCT05010746Mitral Valve Regurgitation (Degenerative or Functional)
Edwards Lifesciences
Not applicable
4
Milan
2023-01-24
Recruiting
Jazz Pharmaceuticals
Phase 3
510
Bologna, Rome, Milan, Rozzano, Turin, Padova
2023-01-23
Recruiting
The Lymphocytic Infiltrate of Lung Tumors.
NCT06470607Lung Cancer, Immune System
Scientific Institute San Raffaele
Observational
70
Milan
2023-01-20
Active, closed
argenx
Phase 2
51
Milan, Pisa, Rome, Rozzano
2023-01-18
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Ancona, Naples, Meldola, Milan, Bari, Cuneo, Perugia, Rome
2023-01-16
Recruiting
Istituto Auxologico Italiano
Observational
66
Milan
2023-01-15
Recruiting
Eli Lilly and Company
Phase 1
677
Milan, Roma
2023-01-12
Active, closed
Bristol-Myers Squibb
Phase 3
516
Rome, Milan, Pisa, Padova, Brescia, Naples, Verona
2023-01-12
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
247
Milan, Rozzano
2023-01-11
Active, closed
Bristol-Myers Squibb
Phase 3
606
Meldola, Milan, Rozzano, Bologna, Catanzaro, Lecce, Pisa, Udine
2023-01-10
Recruiting
Alleviant ALLAY-HF Study
NCT05685303Heart Failure
Alleviant Medical, Inc.
Not applicable
700
Rozzano, Milan
2023-01-10
Active, closed
Zenas BioPharma (USA), LLC
Phase 3
194
Turin, Brescia, Florence, Milan, Verona
2023-01-09
Active, closed
Calcilytix Therapeutics, Inc., a BridgeBio company
Phase 3
67
Milan, Pisa, Roma
2023-01-06
Recruiting
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
NCT05378347Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
Medtronic Cardiovascular
Not applicable
600
Milan, Naples, Torino
2023-01-05
Recruiting
Shionogi
Phase 1/2
24
Milan, Torino, Trieste
2023-01-04
Active, closed
Phase 2b Study of GSK4532990 in Adults With NASH
NCT05583344Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
DrugGSK4532990
GlaxoSmithKline
Phase 2
284
Florence, Milan, Modena, Padova, Palermo, Roma, Rozzano MI, San Giovanni Rotondo FG
2023-01-02
Recruiting
GBG Forschungs GmbH
Phase 2
170
Alessandria, Ancona, Carpi, Lecco, Legnago, Milan, Pavia, Udine
2023-01-02
Recruiting
The Echodynamic Approach
NCT06859047Echocardiography, Transthoracic, Right-heart Hemodynamics
IRCCS Ospedale San Raffaele
Observational
200
Bari, Milan, Pavia
2023-01-01
Recruiting
Istituto Auxologico Italiano
Observational
150
Milan
2023-01-01
By invitation
BioMarin Pharmaceutical
Observational
172
Milan
2023-01-01
Active, closed
Nosocomial Infections in ECMO Patients
NCT05566665Acute Respiratory Distress Syndrome, Nosocomial Infection, Extracorporeal Membrane Oxygenation Complication
Policlinico Hospital
Observational
200
Milan
2023-01-01
Active, closed
Exelixis
Phase 3
317
Rozzano, Candiolo, Arezzo, Bari, Brescia, Meldola, Milan, Naples
2023-01-01
Recruiting
Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
NCT05722275Gastric Cancer, Peritoneal Metastases
Chinese Academy of Sciences
Observational
400
Milan
2023-01-01
Not yet open
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2
20
Milan
2023-01
Active, closed
Novartis Pharmaceuticals
Phase 3
90
Milan, Bassano del Grappa, Novara
2022-12-30
Active, closed
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
NCT05024773Bladder Carcinoma in Situ (CIS)
Fidia Farmaceutici s.p.a.
Phase 3
130
Bergamo, Bologna, Castelfranco Veneto, Florence, Lecce, Milan, Naples, Roma
2022-12-29
By invitation
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
NCT05396105Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II, Hereditary Angioedema Types I and II
DrugDeucrictibant
Pharvaris Netherlands B.V.
Phase 2/3
150
Catania, Milan, Naples, Padova, Palermo, Roma
2022-12-28
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Ancona, Brescia, Milan, Monza, Pisa, Roma, Torino, Tricase
2022-12-23
Recruiting
Azienda Ospedaliero-Universitaria di Parma
Observational
326
Cremona, Florence, Milan, Abano Terme, Verona, Parma
2022-12-22
Recruiting
Meyer Children's Hospital IRCCS
Observational
1,000
Florence, Bari, Belluno, Bologna, Genova, Milan, Modena, Naples
2022-12-22
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,000
Torrette, Castellana Grotte, Bologna, Catania, Foggia, Florence, Modena, Milan
2022-12-21
Recruiting
Montreal Heart Institute
Phase 3
10,000
Foggia, Acquaviva delle Fonti, Ferrara, Ravenna, Milan, Turin, Ancona, Florence
2022-12-21
Active, closed
First in Human Study of AZD9592 in Solid Tumors
NCT05647122Advanced Solid Tumours, Carcinoma Non-small Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms
DrugsAZD9592·Osimertinib·Leucovorin·Adrucil
AstraZeneca
Phase 1
190
Milan, Orbassano, Rozzano, Verona
2022-12-21
Recruiting
Immunocore Ltd
Phase 3
540
Milan, Naples, Perugia, Roma, Siena
2022-12-19
Recruiting
Canadian Cancer Trials Group
Phase 2
393
Florence, Brescia, Lecco, Milan, Rome
2022-12-19
Recruiting
Intervention on New Onset-T1D Children
NCT05767450Type 1 Diabetes
IRCCS San Raffaele
Not applicable
60
Milan
2022-12-16
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Bologna, Genova, Milan, Modena, Naples, Novara, Padova, Pavia
2022-12-16
Recruiting
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 2
37
Novara, Bergamo, Milan, Naples, Padova, Reggio Emilia
2022-12-15
Recruiting
Iperboreal Pharma Srl
Phase 3
170
Ascoli Piceno, Bagno a Ripoli, Bari, Brescia, Chieti, Genova, L’Aquila, Milan
2022-12-14
Active, closed
Hemab ApS
Phase 1/2
57
Florence, Milan
2022-12-13
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
Bergamo, Bologna, Caserta, Milan, Naples, Palmero, Rome
2022-12-13
Recruiting
Pharming Technologies B.V.
Phase 2
180
Bologna, Messina, Milan, Pisa, Roma
2022-12-13
Active, closed
Janssen Research & Development, LLC
Phase 1/2
57
Milan, Naples, Padova, Ravenna, Rome
2022-12-13
Recruiting
Gilead Sciences
Phase 3
1,514
Bari, Bologna, Florence, Genova, Meldola, Milan, Misterbianco, Modena
2022-12-12
Active, closed
Central Hospital, Nancy, France
Not applicable
198
Milan
2022-12-12
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Ancona, Milan
2022-12-09
Active, closed
Celcuity Inc
Phase 3
701
Milan, Modena, Monza, Parma, Prato, Rome, Udine
2022-12-08
Active, closed
Gruppo Oncologico del Nord-Ovest
Phase 2
36
Milan
2022-12-07
Recruiting
Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome
NCT05786235Preeclampsia, Immunologic Disease, Antiphospholipid Antibody Syndrome Primary, Pregnancy Complications
IRCCS San Raffaele
Observational
60
Milan
2022-12-06
Recruiting
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
NCT05732623Colorectal Cancer, Early Onset Colorectal Cancer, Diet Habit, Risk Reduction
San Raffaele University
Observational
2,300
Milan
2022-12-05
Active, closed
AbbVie
Phase 1
288
Milan, Monza
2022-12-05
Active, closed
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 3
129
Bologna, Milan, Rome
2022-12-02
Recruiting
Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule
NCT05693116Nasal Vestibule Carcinoma, Rhinectomy, Nasal Vestibule, Squamous Cell Carcinoma
Istituto Clinico Humanitas
Observational
300
Rozzano, Cagliari, Milan, Varese
2022-12-01
Recruiting
Immediate Versus Delayed Loading of Single Posterior Zirconia Implants
NCT05838365Dental Implant Failed, Peri-implant Mucositis, Peri-Implantitis
University of Milan
Phase 4
220
Milan
2022-12-01
Active, closed
University of Alberta
Not applicable
210
Milan
2022-11-30
Active, closed
Agenus Inc.
Phase 2
234
Milan, Padova
2022-11-30
Recruiting
"How Awareness and Subjectivity Modulate the Placebo Effect"
NCT065331373 Placebo Groups in a Cycle Ergometer Session With Healthy Participants
Fondazione Don Carlo Gnocchi ETS
Not applicable
84
Milan
2022-11-28
Active, closed
AstraZeneca
Phase 3
1,174
Bologna, Brescia, Florence, Genova, Livorno, Meldola, Messina, Milan
2022-11-28
Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
500
Genova, Messina, Milan, Rome
2022-11-28
Recruiting
Niguarda Hospital
Observational
180
Milan
2022-11-28
Active, closed
Sanofi
Phase 2
187
Bolzano, Milan, Rozzano, Rome, Catanzaro, Palermo, Pavia
2022-11-25
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
297
Ancona, Florence, Genova, Messina, Milan, Naples, Orbassano, Potenza
2022-11-23
Active, closed
Mirati Therapeutics Inc.
Phase 2
90
Avellino, Casale Monferrato, Florence, Milan, Orbassano, Ravenna, Roma
2022-11-22
Recruiting
BioMarin Pharmaceutical
Observational
50
Milan
2022-11-22
Active, closed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
NCT05611671Inflammatory Bowel Diseases, Colitis, Ulcerative
DrugZotemtegrast
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
280
Milan, Padova, Rozzano, San Giovanni Rotondo, Segrate
2022-11-21
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
260
Bergamo, Brescia, Florence, Milan, Naples, Palermo, Pisa, Roma
2022-11-21
Active, closed
Novartis Pharmaceuticals
Phase 3
568
Meldola, Milan, Pisa, Roma, Torino
2022-11-21
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
48
Milan, Naples
2022-11-16
Recruiting
Janssen Research & Development, LLC
Phase 2
520
Genova, Milan, Monza, Naples
2022-11-11
Active, closed
AstraZeneca
Phase 3
368
Bologna, Milan, Naples, Padova, Pisa, Roma, Rozzano, Verona
2022-11-10
Active, closed
Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia
NCT07232953Acute Myeloid Leukaemia (AML), Hematopoietic Stem Cell Transplant (HSCT)
DrugsTreosulfan·Fludarabine
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase 2
82
Reggio Calabria, Naples, Modena, Udine, Brescia, Milan, Cuneo, Ancona
2022-11-10
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Ancona, Florence, Genova, Milan, Orbassano, Potenza, Verona
2022-11-08
Recruiting
Bayer
Phase 3
100
Bologna, Florence, Genova, Milan, Roma, Torino
2022-11-08
Recruiting
IRCCS San Raffaele
Not applicable
307
Milan
2022-11-07
Active, closed
Agios Pharmaceuticals, Inc.
Phase 2
87
Milan, Pavia, Rozzano, Turin, Roma
2022-11-07
Active, closed
IRCCS San Raffaele
Observational
500
Milan
2022-11-01
Recruiting
Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression
NCT07146503Depression and Quality of Life, Treatment Resistant Depression (TRD), Anhedonia, Apathy
DrugsIntranasal·Esketamine
Riccardo Guglielmo
Observational
100
Genova, Chieti, Milan, Pavia
2022-11-01
Active, closed
Hoffmann-La Roche
Phase 3
68
Meldola, Milan
2022-11-01
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
80
Avellino, Bassano del Grappa, Florence, Milan, Reggio Calabria, Roma
2022-10-28
Recruiting
Regeneron Pharmaceuticals
Observational
500
Misterbianco, Florence, Udine, Rozzano, Orbassano, Pisa, Catania, Milan
2022-10-26
Active, closed
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
NCT05544929Carcinoma, Non-Small-Cell Lung, Cutaneous Melanoma, Carcinoma, Renal Cell, Carcinoma, Ovarian Epithelial
DrugsKeytruda·Pembrolizumab
Novartis Pharmaceuticals
Phase 1
126
Milan, Modena
2022-10-26
Active, closed
Hoffmann-La Roche
Phase 1
121
Bologna, Meldola, Milan, Pisa
2022-10-26
Active, closed
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
NCT05409976Venous Thromboses, Venous Disease, Venous Leg Ulcer, Venous Stasis
W.L.Gore & Associates
Not applicable
136
Milan, Modena
2022-10-25
Recruiting
The Italian Registry of Malnutrition in Oncology
NCT06337019Cancer, Cancer Metastatic
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
1,500
Bari, Castellana Grotte, Bologna, Meldola, Genova, Milan, Aviano, Padova
2022-10-25
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Bergamo, Bologna, Florence, Milan, Naples, Pavia, Roma, Rozzano
2022-10-25
Recruiting
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
NCT05208762Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma, Triple Negative Breast Neoplasms
DrugsPF-08046054·Keytruda·Pembrolizumab
Seagen, a wholly owned subsidiary of Pfizer
Phase 1
714
Milan, Verona, Bologna
2022-10-25
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Monserrato, Avellino, Rome, Tricase, Brescia, Milan, Naples, Verona
2022-10-24
Active, closed
Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
NCT05358249KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer
DrugsOpnurasib·Trametinib·Ribociclib·Cetuximab
Novartis Pharmaceuticals
Phase 1/2
74
Milan
2022-10-24
Active, closed
AbbVie
Phase 1
283
Meldola, Milan, Rome, Bologna
2022-10-20
Active, closed
Hoffmann-La Roche
Phase 1/2
90
Bologna, Bergamo, Milan, Turin
2022-10-17
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Naples, Modena, Rome, Genoa, Milan, Pavia, Turin, Florence
2022-10-14
Recruiting
IRCCS San Raffaele
Observational
2,500
Milan
2022-10-13
Active, closed
Optilume Registry for Treatment of Stricture of the Anterior Urethra
NCT05479422Anterior Urethral Stricture, Male
European Association of Urology Research Foundation
Observational
150
Milan, Torino, Verona
2022-10-13
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Ancona, Bari, Bologna, Brescia, Catania, Milan, Padova, Palermo
2022-10-13
Active, closed
Gilead Sciences
Phase 3
1,021
Avellino, Cremona, Genova, Milan, Naples, Pavia, Pesaro, Piacenza
2022-10-12
Active, closed
Biogen
Phase 1
62
Milan, Rome
2022-10-10
Recruiting
Italian Registry Chronic Pancreatitis
NCT05733130Chronic Pancreatitis
Associazione Italiana per lo Studio del Pancreas
Observational
1,500
Milan
2022-10-10
Recruiting
Minimally Invasive Treatments of the Thyroid
NCT06333587Papillary Thyroid Microcarcinoma
European Institute of Oncology
Observational
270
Milan
2022-10-10
Recruiting
EMD Serono Research & Development Institute, Inc.
Observational
700
Misterbianco, Milan, Modena, Naples, Rome, Torino, Varese
2022-10-04
Active, closed
Janssen Research & Development, LLC
Phase 1
196
Bologna, Meldola, Milan, Rozzano
2022-10-04
Active, closed
Eli Lilly and Company
Phase 3
8,000
Ancona, Bergamo, Bologna, Brindisi, Candiolo, Florence, Genova, Milan
2022-10-04
Recruiting
Ionis Pharmaceuticals, Inc.
Observational
32
Milan
2022-10-03
Recruiting
University of Milano Bicocca
Not applicable
255
Milan
2022-10-03
Recruiting
The PseAn Study - Study Protocol
NCT05627908Abdominal Trauma, Follow-up in Abdominal Trauma
Niguarda Hospital
Observational
385
Milan
2022-10-01
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
1,200
Milan
2022-10-01
Recruiting
Istituto Auxologico Italiano
Observational
3,000
Mascalucia, Bari, Milan, Reggio Emilia, Trieste
2022-10-01
Recruiting
Ellipses Pharma
Phase 1/2
265
Aviano, Bologna, Milan, Roma, Torino
2022-09-30
Active, closed
Copenhagen University Hospital, Rigshospitalet
Observational
991
Milan
2022-09-28
Active, closed
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
NCT05347095Fistulizing Crohns Disease, Perianal Crohns Disease
DrugGuselkumab
Janssen-Cilag Ltd.
Phase 3
288
Milan, Negrar ( Ve), Pisa, Rho, Roma, Rozzano, San Giovanni Rotondo
2022-09-27
Recruiting
Janssen Research & Development, LLC
Phase 2/3
201
Catania, Genova, Milan, Naples, Orbassano, Pavia, Roma, Rozzano
2022-09-23
Active, closed
Kite, A Gilead Company
Phase 3
231
Bergamo, Bologna, Milan, Reggio Emilia, Rozzano
2022-09-22
Active, closed
Genmab
Phase 3
549
San Giovanni Rotondo, Milan, Turin, Aviano, Rome, Candiolo, Alessandria, Bari
2022-09-20
Recruiting
Paolo Ghia
Phase 2
55
Milan
2022-09-19
Active, closed
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
NCT05462717Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor
DrugElironrasib
Revolution Medicines, Inc.
Phase 1
222
Milan, Naples, Orbassano, Pavia, Verona
2022-09-19
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Bari, Catania, Messina, Milan, Monserrato, Monza, Negrar, Palermo
2022-09-19
Active, closed
Evaxion Biotech A/S
Phase 2
17
Milan, Naples
2022-09-19
Recruiting
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
NCT05377047Breast Cancer Stage IV, Oligometastatic Disease
Vastra Gotaland Region
Phase 3
345
Florence, Milan
2022-09-19
Active, closed
Vir Biotechnology, Inc.
Phase 2
95
Milan, Pisa
2022-09-17
Active, closed
Lung Cancer Prevention Screening Programme in Italy
NCT05766046Lung Cancer, COPD (Chronic Obstructive Pulmonary Disease) With Acute Lower Respiratory Infection, Cardiovascular Diseases
Ugo Pastorino
Not applicable
7,324
Milan
2022-09-17
Active, closed
AstraZeneca
Phase 3
594
Aviano, Livorno, Meldola, Milan, Monza, Naples, Padova, Parma
2022-09-15
Active, closed
Biogen
Phase 2/3
450
Bologna, Brescia, Florence, Genova, Milan, Naples, Roma
2022-09-13
Recruiting
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
429
Bergamo, Milan, Pavia, Varese, Padova, Verona, Vicenza, Alessandria
2022-09-08
Active, closed
Redx Pharma Ltd
Phase 2
48
Ancona, Catania, Foggia, Lecce, Milan, Modena, Roma, Verona
2022-09-08
Recruiting
Universitaire Ziekenhuizen KU Leuven
Phase 4
292
Milan, Castellana Grotte, Florence
2022-09-08
Recruiting
AstraZeneca
Phase 2
454
Florence, Genova, Milan, Naples, Rome
2022-09-06
Recruiting
GlaxoSmithKline
Phase 3
109
Bologna, Catania, Milan, Naples, Novara, Pavia, Roma, Treviso
2022-09-06
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
DrugTreprostinil
United Therapeutics
Phase 3
1,850
Modena, Rome, Milan, Catania, Siena, Ancona, Forlì, Roma
2022-09-06
Active, closed
Dyne Therapeutics
Phase 1/2
127
Milan, Rome
2022-09-05
Recruiting
IRCCS San Raffaele
Observational
30
Milan
2022-09-02
By invitation
Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis
NCT04814693Acute Pancreatitis, Necrosis; Pancreas, Acute (Infectious)
Erasmus Medical Center
Not applicable
60
Milan, Roma
2022-09-02
By invitation
Niguarda Hospital
Observational
1,500
Milan
2022-09-01
By invitation
Ottawa Heart Institute Research Corporation
Observational
3,500
Milan
2022-09-01
Recruiting
Stemline Therapeutics, Inc.
Phase 1/2
73
Ancona, Candiolo, Meldola, Messina, Milan, Modena, Monza, Naples
2022-08-31
Recruiting
Asciminib Roll-over Study
NCT04877522Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
DrugsAsciminib single agent·Bosutinib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 4
347
Milan, Roma, Naples
2022-08-30
Recruiting
Smith & Nephew, Inc.
Not applicable
234
Milan, Roma
2022-08-30
Recruiting
Acrivon Therapeutics
Phase 2
350
Aviano, Catania, Milan, Naples, Pieve Emanuele, Roma, Turin
2022-08-29
Active, closed
Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer
NCT05403385Metastatic NSCLC - Non-Small Cell Lung Cancer, Locally Advanced NSCLC - Non-Small Cell Lung Cancer
DrugsPemetrexed·Carboplatin
iTeos Therapeutics
Phase 2
36
Milan, Rozzano
2022-08-26
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
845
San Giovanni Rotondo, Milan, Rozzano, Roma, Torino, Florence, Palermo, Pisa
2022-08-26
Recruiting
DMCRN-02-001: Assessing Pediatric Endpoints in DM1
NCT05224778Congenital Myotonic Dystrophy, CDM
Virginia Commonwealth University
Observational
50
Milan
2022-08-24
Active, closed
Biogen
Phase 2
416
Tricase, Cefalù, Arzignano VI, Brescia, Milan, Perugia, Roma
2022-08-24
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
410
Salerno, Rome, Baggiovara, Ponderano (Biella), Florence, Milan, Monza, Pisa
2022-08-23
Active, closed
Sanofi
Phase 2/3
1,856
Milan, Rozzano, Naples, Rome, Turin, Bologna, Catania, Chieti
2022-08-22
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Bologna, Florence, Forlì, Milan, Misterbianco, Naples, Padova, Pisa
2022-08-17
Active, closed
Gilead Sciences
Phase 2/3
689
Milan, Modena, Roma, Torino
2022-08-16
Active, closed
AbbVie
Observational
785
Castellana Grotte, Rozzano, Milan, Naples, Rome, Negrar, Palermo, Pisa
2022-08-15
Active, closed
Dyne Therapeutics
Phase 1/2
86
Rome, Milan
2022-08-12
Active, closed
AstraZeneca
Phase 2
194
Candiolo, Milan, Naples, Padova, Perugia, Roma, Siena
2022-08-11
Active, closed
Novo Nordisk A/S
Phase 3
412
Milan, Florence, Genova, Naples, Roma, Rome
2022-08-10
Active, closed
IRCCS San Raffaele
Observational
36
Milan
2022-08-10
Active, closed
GlaxoSmithKline
Phase 3
3,038
Genoa, Milan
2022-08-10
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
DrugsAbraxane·Nab-paclitaxel·Gemcitabine
Panbela Therapeutics, Inc.
Phase 2/3
600
San Giovanni Rotondo, Meldola, Reggio Emilia, Milan, Candiolo, Pisa, Terni, Verona
2022-08-08
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Bari, Bologna, Milan, Orbassano, Padova, Ravenna, Roma, Rome
2022-08-05
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Ancona, Milan, Salerno, Udine, Naples
2022-08-04
Active, closed
Genentech, Inc.
Phase 3
373
Modena, Rome, Genoa, Milan, Torrette Di Ancona, Verona
2022-08-03
Active, closed
AstraZeneca
Phase 3
341
Avellino, Aviano, Catania, Meldola, Milan, Modena, Monserrato, Naples
2022-08-03
Active, closed
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
NCT05489237Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumor (GIST), Digestive System Disease, Gastrointestinal Diseases
DrugIDRX-42
IDRX, Inc., a wholly owned subsidiary of GSK, LLC
Phase 1
276
Milan
2022-08-03
Active, closed
Bausch Health Americas, Inc.
Phase 3
466
Milan, Naples, Novara, Palermo, Rozzano
2022-08-03
Recruiting
D3 Bio (Wuxi) Co., Ltd
Phase 1/2
442
Candiolo, Milan, Naples, Rome, Siena
2022-08-03
Active, closed
Eli Lilly and Company
Phase 4
780
Bari, Naples, Milan, Moncalieri, Olbia, Palermo, Pisa, Catanzaro
2022-08-01
Recruiting
Pietro Mortini, MD, Prof.
Observational
200
Milan
2022-08-01
Recruiting
Janssen Research & Development, LLC
Phase 1/2
225
Milan, Pisa
2022-07-29
Active, closed
Gilead Sciences
Phase 3
443
Bari, Bologna, Brescia, Genova GE, Lecco, Lucca, Milan, Monza
2022-07-25
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Ibrutinib
Loxo Oncology, Inc.
Phase 3
737
Alessandria, Bologna, Meldola, Milan, Reggio Emilia
2022-07-22
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Bari, Catania, Messina, Milan, Monopoli, Monserrato, Monza, Negrar ( Ve)
2022-07-22
Recruiting
Research Maatschap Cardiologen Rotterdam Zuid
Phase 4
1,656
Bergamo, Ferrara, Genova, Milan, Naples, Roma
2022-07-22
Recruiting
European Institute of Oncology
Observational
320
Milan
2022-07-21
Active, closed
Gilead Sciences
Phase 3
623
Bari, Bologna, Brescia, Genova GE, Lecco, Lucca, Milan, Monza
2022-07-20
Active, closed
Incyte Corporation
Phase 1/2
53
Ravenna, Milan, Pavia, Monza, Candiolo, Pisa, Perugia
2022-07-19
Active, closed
Hoffmann-La Roche
Phase 3
922
Naples, Reggio Emilia, Rimini, Rome, Brescia, Milan, Rozzano, Misterbianco (CT)
2022-07-18
Recruiting
Ciceri Fabio
Observational
500
Milan
2022-07-18
Active, closed
First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours
NCT05495295Malignant Tumor, Advanced Solid Tumor, Glioblastoma Multiforme, Metastatic Cancer
Phost'In Therapeutics
Phase 1
149
Milan, Reggio Emilia
2022-07-18
Recruiting
Castagna Antonella
Observational
1,500
Milan
2022-07-17
Active, closed
Merck Sharp & Dohme LLC
Phase 2
60
Rome, Milan, Palermo, Florence, Alessandria
2022-07-14
Active, closed
GlaxoSmithKline
Phase 3
163
Bari, Brescia, Florence, Milan, Pavia, Pisa, Roma, Torrette AN
2022-07-14
Recruiting
Istituto Auxologico Italiano
Observational
3,000
Milan
2022-07-12
Active, closed
Pfizer
Phase 2
108
Monserrato, Naples, Guastalla, San Giovanni Rotondo, Milan, Candiolo, Livorno, Pisa
2022-07-11
Active, closed
Novartis Pharmaceuticals
Phase 3
610
Milan, Rozzano, Torino
2022-07-08
Active, closed
Daiichi Sankyo
Phase 3
586
Bari, Chieti, Lucca, Milan, Orbassano, Parma, Perugia, Roma
2022-07-08
Recruiting
AIOCC Italian Registry on Head and Neck Carcinomas
NCT06248944Head and Neck Carcinoma
Italian Head&Neck Society
Observational
7,000
Candiolo, Florence, Lecce, Milan, Pavia, Roma, Verona
2022-07-06
Active, closed
Incyte Corporation
Phase 1
291
Milan, Naples, Rome, Rozzano, Verona
2022-07-05
Active, closed
Janssen Research & Development, LLC
Phase 2
36
Ancona, Milan, Pavia, Roma
2022-07-05
Recruiting
Pfizer
Phase 4
210
Bari, Perugia, Rome, Candiolo, Padova, Bologna, Milan, Naples
2022-07-05
Recruiting
Octapharma
Phase 3
38
Bergamo, Milan, Padua, Roma
2022-07-01
Recruiting
Post COVID-19 Condition
NCT05531773COVID-19
Euresist Network GEIE
Observational
2,300
Rome, Milan
2022-07-01
Active, closed
Primary Mediastinal Large B-cell Lymphoma With CNS Involvement
NCT06024694Primary Mediastinal Large B-cell Lymphoma (PMBCL)
IRCCS San Raffaele
Observational
45
Milan
2022-06-30
Active, closed
Corcept Therapeutics
Phase 3
381
Catania, Legnago, Milan, Pavia, Roma, Rome, Torino, Treviso
2022-06-29
Active, closed
Istituto Auxologico Italiano
Observational
10
Milan
2022-06-24
Recruiting
Prospective Observational Study to Characterize Patients Treated at Internal Medicine Clinics
NCT05780099Respiratory Disease, Cardiovascular Diseases, Infectious Disease, Critical Illness
IRCCS San Raffaele
Observational
50,000
Milan
2022-06-24
Active, closed
Celgene
Phase 3
939
Rome, Bologna, Catania, Genova, Milan, Novara, Pavia, Pisa
2022-06-23
Recruiting
Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
NCT06822855Classical Hodgkin Lymphoma, Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory
Azienda USL Reggio Emilia - IRCCS
Observational
755
Milan, Reggio Emilia, Avellino, Brescia, Padova, Palermo, Perugia, Piacenza
2022-06-23
Active, closed
Hoffmann-La Roche
Phase 4
136
Naples, Rome, Milan, Florence
2022-06-20
Recruiting
Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens
NCT06327568Anal Intraepithelial Neoplasia 2, Anal Intraepithelial Neoplasia 1, Anal Cancer, High-Risk Cancer
European Institute of Oncology
Observational
200
Milan
2022-06-17
Active, closed
ADC Therapeutics S.A.
Phase 1
154
Bergamo, Bologna, Brescia, Milan
2022-06-17
Active, closed
RECORDATI GROUP
Observational
206
Ancona, Milan, Naples, Roma
2022-06-13
Recruiting
IRCCS Burlo Garofolo
Observational
20
Florence, Milan, Trieste
2022-06-13
Recruiting
Nuvalent Inc.
Phase 1/2
840
Ancona, Bari, Milan, Padova, Ravenna, Rome
2022-06-09
Active, closed
Sanofi
Phase 2
48
Bologna, Rome, Brescia, Milan
2022-06-09
Recruiting
Telios Pharma, Inc.
Phase 1/2
70
Bologna, Milan, Perugia
2022-06-09
Recruiting
Astellas Pharma Global Development, Inc.
Phase 1
398
Milan, Rozzano, Verona
2022-06-07
Recruiting
BioMarin Pharmaceutical
Observational
450
Bologna, Florence, Milan, Naples, Padova, Palermo, Rome
2022-06-06
Active, closed
Hoffmann-La Roche
Phase 2/3
97
Rome, Genoa, Milan, Ancona
2022-06-02
Active, closed
AstraZeneca
Phase 1/2
174
Candiolo, Milan, Orbassano, Padova
2022-06-02
Recruiting
Pirfenidone to Prevent Fibrosis in Ards.
NCT05075161Acute Respiratory Distress Syndrome (ARDS)
DrugPirfenidone
Università Vita-Salute San Raffaele
Phase 3
130
Milan, Alessandria, Bari, Brescia, Cagliari, Merano, Palermo, Pisa
2022-06-01
Recruiting
The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
NCT05483374Head and Neck Cancer, Nasopharynx Cancer, Nasal Cavity and Paranasal Sinus Cancer, Salivary Gland Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
13,600
Genova, Milan, Rozzano, Pavia, Prato, Roma
2022-05-31
Active, closed
HEAL-IST IDE Trial
NCT05280093Inappropriate Sinus Tachycardia
AtriCure, Inc.
Not applicable
142
Milan
2022-05-31
Recruiting
Dimerix Bioscience Pty Ltd
Phase 3
286
Bari, Bologna, Genova, Milan, Pavia, Roma, Torino
2022-05-30
Recruiting
CardioPulmonary Resuscitation With Argon (CPAr) Trial
NCT05482945Cardiac Arrest, Out-Of-Hospital, Cardiac Arrest With Successful Resuscitation
Mario Negri Institute for Pharmacological Research
Phase 2
120
Genova, Monza, Milan, Parma, Pordenone, Reggio Emilia, Roma, Trento
2022-05-30
Active, closed
Genentech, Inc.
Observational
400
Udine, Rome, Milan
2022-05-27
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Florence, Genova, Milan, Padova, Pavia, Roma, Torino, Trieste
2022-05-23
Active, closed
Hoffmann-La Roche
Phase 3
188
Chieti, Bari, Rome, Milan, Catania
2022-05-19
Recruiting
Electra Therapeutics Inc.
Phase 2/3
156
Florence, Genova, Milan, Monza, Padova, Roma, Trieste
2022-05-19
Active, closed
IO Biotech
Phase 3
407
Ancona, Aviano, Bari, Candiolo, Genova, Meldola, Milan, Naples
2022-05-17
Active, closed
LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients
NCT05410951Lobular Breast Carcinoma, Lobular in Situ Breast Carcinoma, BRCA1 Mutation, BRCA2 Mutation
European Institute of Oncology
Observational
800
Milan
2022-05-16
Active, closed
AstraZeneca
Phase 3
644
Borgo San Lorenzo, Catanzaro, Genova, Livorno, Milan, Modena, Naples, Province of Macerata
2022-05-16
Recruiting
Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System
NCT05493514Multiple Sclerosis, Stroke, Parkinson Disease, Acquired Brain Injury
Fondazione Don Carlo Gnocchi ETS
Observational
260
Milan
2022-05-13
Recruiting
Hoffmann-La Roche
Phase 2
40
Rome, Genoa, Milan
2022-05-12
Recruiting
Innovacell GmbH
Phase 3
290
San Donato Milanese, Milan
2022-05-11
Recruiting
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
742
Milan
2022-05-11
Recruiting
Type 2 Diabetes, Obesity and Cortisol Excess
NCT05759637Diabetes Mellitus, Type 2, Obesity, Cortisol; Hypersecretion
Istituto Auxologico Italiano
Observational
3,200
Milan, Roma, Siena, Udine
2022-05-06
Recruiting
Centervue SpA
Observational
200
Milan, Roma
2022-05-06
Recruiting
Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
NCT05807256Rheumatic Diseases, Fertility Disorders, Pregnancy, High Risk, Pregnancy Complications
IRCCS San Raffaele
Observational
500
Milan
2022-05-04
Active, closed
Sanofi
Phase 3
104
Milan, Naples, Bologna
2022-05-03
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
372
Milan, Aviano, Roma, Padova, Pisa, Terni
2022-05-03
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Gallarate, Ponderano, Rome, Genoa, Milan, Montichiari, Orbassano, Cefalù
2022-05-03
Recruiting
PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
NCT05055648Esophageal Cancer, Radiotherapy, Side Effect, Proton Therapy
University of Aarhus
Phase 3
396
Milan, Pavia, Trento
2022-05-01
Recruiting
SK Life Science, Inc.
Phase 3
252
Genoa, Milan, Verona, Florence
2022-04-28
Rows per page Showing 1501–2000 of 2846
Previous 2 3 4 5 6 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/milan?page=4

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2,846 of those studies with a site in Milan.

How many clinical trials are recruiting in Milan?

1,595 of the 2,846 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 145 have not yet opened recruitment, 1,033 are active but closed to new participants, and 73 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.